Stay updated on LY2880070 in Advanced Cancer Clinical Trial
Sign up to get notified when there's something new on the LY2880070 in Advanced Cancer Clinical Trial page.

Latest updates to the LY2880070 in Advanced Cancer Clinical Trial page
- CheckyesterdayChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedAdded a consolidated Locations section listing sites in Massachusetts, Michigan, Alberta, British Columbia, Ontario, and Quebec, and removed the old per-location subsections for those regions.SummaryDifference0.5%

- Check45 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check52 days agoChange DetectedAdded clarifications that publications are provided voluntarily by the study team and are automatically filled from PubMed, and updated the revision metadata to v3.3.1. Removed older wording describing PubMed-generated publications and the reference to revision v3.2.0; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedRemoved the banner about government funding and NIH operating status. The study details, eligibility criteria, and locations remain unchanged.SummaryDifference0.3%

- Check74 days agoChange DetectedAdded a related publication abstract LY2880070 with gemcitabine in cancer (ASCO 2020), the sponsor Esperas Pharma Inc., and a note for Helpful Links Provided by Esperas Pharma Inc.; to avoid alerts for small changes, set an alert condition below.SummaryDifference0.4%

Stay in the know with updates to LY2880070 in Advanced Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LY2880070 in Advanced Cancer Clinical Trial page.